Showing 4121-4130 of 5623 results for "".
- Foundation Fighting Blindness Announces Leadership Changeshttps://modernod.com/news/foundation-fighting-blindness-announces-leadership-changes/2480924/The Foundation Fighting Blindness announced the promotions of Jason Menzo to chief executive officer of the Foundation, and Russell Kelley, PhD, MBA, to managing director of the Retinal Degeneration (RD) Fund, the venture arm of the Foundation, effective Ju
- OliX Pharmaceuticals Subsidiary mCureX Announces mRNA Technology Collaboration with ToolGen for Rare Eye Diseasehttps://modernod.com/news/olix-pharmaceuticals-subsidiary-mcurex-announces-mrna-technology-collaboration-with-toolgen-for-rare-eye-disease/2480920/OliX Pharmaceuticals, a\ developer of RNAi therapeutics, announced that the company’s subsidiary, mCureX Therapeutics, has recently signed a contract for joint research with ToolGen to advance the development of gene therapy for rare eye diseases, leveraging mCureX’s mRNA technol
- University of Wisconsin Eye Research Uncovers How Stem Cell Photoreceptors Reach Their Targetshttps://modernod.com/news/uw-eye-research-uncovers-how-stem-cell-photoreceptors-reach-their-targets/2480915/A new study reveals how photoreceptors grown from stem cells might extend biological wires, known as axons, to contact existing neurons. The finding has implications for future treatment of retinal diseases that cause blindness, including age-related macular degeneration (AMD) and rare disea
- New Study Shows Intraocular Lens Centration and Stability May Be Improved When Zepto Capsulotomy Platform is Used with Purkinje Reflectionshttps://modernod.com/news/new-study-shows-intraocular-lens-centration-and-stability-may-be-improved-when-zepto-capsulotomy-platform-is-used-with-purkinje-reflections/2480912/Centricity Vision announced the publication of a clinical study describing how to use Purkinje reflections at patient fixation for capsulotomy centration and 360-degree capsular overlap with the Zepto platform to help achieve improved visual outcomes. Published in the Journal
- NIH Researchers Discover New Genetic Eye Diseasehttps://modernod.com/news/nih-researchers-discover-new-genetic-eye-disease/2480909/Researchers from the National Eye Institute (NEI) have identified a new disease that affects the macula. Scientists report their findings on the novel macular dystrophy, which is yet to be named, in JAMA Ophthalmology. Macular dystrophies are disorders that usually cause central visual l
- iSTAR Medical Presents Positive Results for MINIject Across Three International Glaucoma Trialshttps://modernod.com/news/istar-medical-presents-positive-results-for-miniject-across-three-international-glaucoma-trials/2480908/iSTAR Medical presented 2-year safety and efficacy results in a meta-analysis of its STAR-I, STAR-II and STAR-III clinical trials for
- Samsara Vision and Lansheng Medical “MyVision” Announce Collaboration to Commercialize the SING IMT in Chinahttps://modernod.com/news/samsara-vision-and-lansheng-medical-myvision-announce-collaboration-to-commercialize-the-sing-imt-in-china/2480907/Samsara Vision announced it will collaborate with Lansheng Medical “MyVision,” a China-based company focused on ophthalmology, to develop a clinical and commercial organization to support Samsara Vision’s SING IMT (Smaller-Incision New-Generation Implantable Miniature
- First-of-its-Kind Study Finds Artificial Intelligence Screenings Improve Eye Care Access in Sub-Saharan Africahttps://modernod.com/news/first-of-its-kind-study-finds-artificial-intelligence-screenings-improve-eye-care-access-in-sub-saharan-africa/2480906/Orbis announced new research findings demonstrating that diabetic retinopathy screenings supported by artificial intelligence (AI) enhanced patients’ speed and uptake of referral services in Rwanda, which can help reduce vision loss due to diabetes in the region. The study is
- Aurion Biotech Appoints Michael Goldstein, MD, as President and Chief Medical Officerhttps://modernod.com/news/aurion-biotech-appoints-dr-michael-goldstein-as-president-and-chief-medical-officer/2480904/Aurion Biotech announced it has appointed Michael Goldstein, MD, as president and chief medical officer. Dr. Goldstein will lead the company’s clinical strategy, development and operations; medical affairs; and manufacturing and quality teams for its first product candidate, a cel
- Rayner Acquires Stake in Sustainable Surgical Instrument Belgian Manufacturer Hasa Optixhttps://modernod.com/news/rayner-acquires-stake-in-sustainable-surgical-instrument-belgian-manufacturer-hasa-optix/2480900/Rayner announced that it has entered into a commercial partnership and concurrently acquired a stake in Hasa Optix, a Brussels-based manufacturer of single use ophthalmic surgical instruments and instrument sets. The investment closed June 7, 2022. Financial terms of the deal